首页>
外国专利>
Combination radiotherapy of bone-localized radiopharmaceuticals and tubulin interacting compounds
Combination radiotherapy of bone-localized radiopharmaceuticals and tubulin interacting compounds
展开▼
机译:骨局部放射性药物与微管蛋白相互作用化合物的联合放疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to a method for the improved treatment of a cancerous disease in a patient and/or for the palliation of pain associated with cancer diseases, comprising the administration of a tubulin interacting compound in combination with a bone-localising radiopharmaceutical to said patient in an effective amount that will not cause any substantial ablation of the bone marrow of said patent. In particular, the cancerous disease is selected from the group of cancer diseases, comprising multiple myeloma, leukaemia, lymphoma, breast cancer, prostate cancer, gynecologic cancer, gastric cancer ovarian cancer, lung cancer and/or renal cell carcinoma. In a preferred embodiment, the bone-localising radiopharmaceutical is samarium Sm 153 lexidronam and the tubulin interacting compound is docetaxel.
展开▼